PROC (Procaps Group Corp) Rasio rega marang prakiraan pendapatan
Does the CDMO model ensure stable cash flow and high margins? The forward P/S metric provides the answer, and the indicator has now reached 0.60. Procaps Group S.A. (PROC) revenues rely on pharmacy chains and dietary supplements in Latin America. Simultaneously, the company is upgrading extrusion equipment and control systems at its plants to maintain maximum capacity utilization.
Rincian metrik lan analitis perusahaan Procaps Group Corp (PROC)
- rega pasar lan target rega analis:
- indikator valuasi pasar bisnis:
- indikator nilai buku ekuitas:
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal Procaps Group S.A.|PROC - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Procaps Group S.A.|PROC - Gunggung tanggungan utang perusahaan|Rasio utang marang kapitalisasi buku Procaps Group Corp|PROC - Gunggunge utang jangka dawa|Kewajiban jangka cendhak perusahaan Procaps|Rasio cepet procapsgroup.com
- data bathi bisnis lan rasio investasi:
PROC - Bathi resik taunan|Bathi sing dikarepake Procaps Group S.A.|PROC - Nilai perusahaan marang bathi resik|Rega marang bathi mangsa ngarep Procaps Group SA|PROC - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Procaps Group Corp|PROC - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Procaps|PROC - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan procapsgroup.com|PROC - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Procaps Group S.A.
- rincian pendapatan lan dodolan:
Pambiji fundamental:PROC (Procaps)
Forward P/S determines the market value of an asset relative to projected revenue, allowing investors to filter out "value traps" and identify fundamentally resilient issuers. By analyzing the forward price-to-sales ratio on GURU.Markets, an investor can assess the capitalization efficiency of Procaps Group S.A. (PROC), whose unique expertise in creating complex capsules and plant certifications ensure a high business valuation through robust production barriers.
Analisis perusahaan pesaing
Rasio rega marang prakiraan pendapatan Haleon HLN|KVUE (Kenvue Inc) - Rega mangsa ngarep marang pendapatan|VRNA - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan MENS (Jyong Bio)|Ligand Pharmaceuticals (LGND) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep amneal.com (AMRX)|PRGO (Perrigo) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Alvotech S.A. (ALVO)|Multiplikator Forward P/S LQDA|Multiplikator Forward P/S Galapagos Corp (GLPG)|Rasio rega marang prakiraan pendapatan ANI Pharmaceuticals ANIP|MNKD (mannkindcorp.com) - Rega mangsa ngarep marang pendapatan|AMPH - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Pacira Pharmaceuticals PCRX|SPRY (ARS Pharma) - Multiplikator forward rega marang pendapatan|Theravance Corp - Rega forward marang dodolan|AQST (Aquestive Therapeutics) - Multiplikator Forward P/S|SCPH - Prakiraan rega marang pendapatan|Rasio rega marang prakiraan pendapatan Tectonic Therapeutic, Inc. (TECX)|TNXP (Tonix Pharma) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan China SXT Pharmaceuticals, Inc. SXTC|Eupraxia Pharmaceuticals, Inc. (EPRX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|BHST: Multiplikator forward rega marang pendapatan|EXOZ - Multiplikator Forward P/S|oramed.com (ORMP) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan ENTX (Entera Bio)|Multiplikator forward rega marang pendapatan HYFT|ABVC: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Cumberland Pharmaceuticals (CPIX)|Rasio kapitalisasi marang dodolan sing dikarepake quantumbiopharma.com|FibroGen - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Telomir Pharmaceuticals Inc (TELO)|Rani Therapeutics Inc - Multiplikator Forward P/S|SNYR - Multiplikator Forward P/S|RLYB (rallybio.com) - Multiplikator forward rega marang pendapatan|LEXX - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Pulmatrix|Pheton - Rega mangsa ngarep marang pendapatan|Rasio rega marang prakiraan pendapatan Aptorum Group Limited (APM)|LYRA (Lyra Therapeutics Inc) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Impact BioMedical Inc IBO|TNF Pharmaceuticals Inc. (TNFA) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|cbdMD Corp - Multiplikator Forward P/S|PainReform Ltd (PRFX) - Multiplikator forward rega marang pendapatan|altamiratherapeutics.com (CYTO) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan LIPO (Lipella Pharma)|OPTN (OptiNose, Inc.) - Multiplikator Forward P/S|PIRS: Rega forward marang dodolan|Multiplikator Forward P/S PTPI|Multiplikator Forward P/S Qilian International Holding Group (QLI)|Rasio rega marang prakiraan pendapatan ACELYRIN, Inc. SLRN|Rega forward marang dodolan TFFP
